Anne Samuel

Stock Analyst at JP Morgan

(1.3)
# 1796
Out of 5,376 analysts
81
Total ratings
Success rate
Average return
20 Stocks
Name Action PT Current % Upside Ratings Updated
DOCS Doximity
Maintains: Neutral
63 60
57.48 4.38% 6 May 27, 2025
IQV IQVIA Hldgs
Maintains: Overweight
232 177
154.81 14.33% 7 May 19, 2025
OMCL Omnicell
Maintains: Neutral
44 36
28.05 28.34% 5 Mar 20, 2025
VEEV Veeva Systems
Maintains: Neutral
218 249
279.13 -10.79% 6 Mar 20, 2025
EVH Evolent Health
Maintains: Overweight
13 12
9.26 29.59% 12 Mar 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
17 23
20.98 9.63% 7 Jan 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
27 28
26.22 6.79% 2 Sep 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
21 19
22.05 -13.83% 4 Sep 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
19 21
21.89 -4.07% 3 Sep 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
10 13
3.62 259.12% 3 Sep 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
24 27
37.68 -28.34% 2 Aug 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
7 5
3.79 31.93% 1 Jul 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
86 108
101.33 6.58% 7 Apr 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
20 11
n/a n/a 3 Dec 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
30 25
n/a n/a 1 Dec 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
19 20
n/a n/a 1 Nov 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
32 31
n/a n/a 2 Sep 6, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
12
n/a n/a 1 Jul 12, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
14 15
n/a n/a 4 Apr 24, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
148 159
n/a n/a 4 Apr 24, 2018